Staphylococcus lugdunensis - Not the Average Coagulase-Negative Staphylococcus Species

Clinical Microbiology Newsletter

Volumn 30, Issue 8, 2008, Pages 55-62

  Frank, Kristi L ^a   Patel, Robin ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; CEFALOTIN; CEFAMANDOLE; CEFAZOLIN; CEFTOBIPROLE; CEPHALOSPORIN; CLINDAMYCIN; COAGULASE; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; MACROLIDE; MOXIFLOXACIN; NAFCILLIN; OXACILLIN; PENICILLIN G; RIFAMPICIN; STREPTOMYCIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIUM ISOLATE; BIOFILM; COAGULASE NEGATIVE STAPHYLOCOCCUS; COMMENSAL; HUMAN; NONHUMAN; PATHOGENESIS; PATHOGENICITY; PROSTHESIS INFECTION; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION; STAPHYLOCOCCUS LUGDUNENSIS; VIRUS ATTACHMENT;

EID: 41249101814     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinmicnews.2008.03.004     Document Type: Article

References (76)

1. Freney J., et al. Staphylococcus lugdunensis sp. nov. and Staphylococcus schleiferi sp. nov., two species from human clinical specimens. Int. J. Syst. Bacteriol. 38 (1988) 168-172
2. Becker K., et al. Does nasal cocolonization by methicillin-resistant coagulase-negative staphylococci and methicillin-susceptible Staphylococcus aureus strains occur frequently enough to represent a risk of false-positive methicillin-resistant S. aureus determinations by molecular methods?. J. Clin. Microbiol. 44 (2006) 229-231
3. Koziol-Montewka M., et al. The investigation of Staphylococcus aureus and coagulase-negative staphylococci nasal carriage among patients undergoing haemodialysis. Microbiol. Res. 161 (2006) 281-287
4. van der Mee-Marquet N., et al. Staphylococcus lugdunensis infections: high frequency of inguinal area carriage. J. Clin. Microbiol. 41 (2003) 1404-1409
5. Frank K.L., del Pozo J.L., and Patel R. From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis. Clin. Microbiol. Rev. 21 (2008) 111-133
6. Herchline T.E., and Ayers L.W. Occurrence of Staphylococcus lugdunensis in consecutive clinical cultures and relationship of isolation to infection. J. Clin. Microbiol. 29 (1991) 419-421
7. Kawamura Y., et al. Distribution of Staphylococcus species among human clinical specimens and emended description of Staphylococcus caprae. J. Clin. Microbiol. 36 (1998) 2038-2042
8. Akiyama H., et al. Coagulase-negative staphylococci isolated from various skin lesions. J. Dermatol. 25 (1998) 563-568
9. Asnis D.S., et al. Staphylococcus lugdunensis breast abscess: is it real?. Clin. Infect. Dis. 36 (2003) 1348
10. Tan T.Y., Ng S.Y., and Ng W.X. Clinical significance of coagulase-negative staphylococci recovered from nonsterile sites. J. Clin. Microbiol. 44 (2006) 3413-3414
11. Etienne J., et al. Staphylococcus lugdunensis endocarditis. Lancet i (1989) 390
12. Anguera I., et al. Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles. Heart 91 (2005) e10
13. Koh T.W., Brecker S.J., and Layton C.A. Successful treatment of Staphylococcus lugdunensis endocarditis complicated by multiple emboli: a case report and review of the literature. Int. J. Cardiol. 55 (1996) 193-197
14. Vandenesch F., et al. Endocarditis due to Staphylococcus lugdunensis: report of 11 cases and review. Clin. Infect. Dis. 17 (1993) 871-876
15. Patel R., et al. Frequency of isolation of Staphylococcus lugdunensis among staphylococcal isolates causing endocarditis: a 20-year experience. J. Clin. Microbiol. 38 (2000) 4262-4263
16. Trampuz A., et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N. Engl. J. Med. 357 (2007) 654-663
17. Sampathkumar P., Osmon D.R., and Cockerill III F.R. Prosthetic joint infection due to Staphylococcus lugdunensis. Mayo Clin. Proc. 75 (2000) 511-512
18. Camacho M., et al. Three-year outcome in a patient with Staphylococcus lugdunensis discitis. Joint Bone Spine 69 (2002) 85-87
19. Greig J.M., and Wood M.J. Staphylococcus lugdunensis vertebral osteomyelitis. Clin. Microbiol. Infect. 9 (2003) 1139-1141
20. Murdoch D.R., et al. Vertebral osteomyelitis due to Staphylococcus lugdunensis. J. Clin. Microbiol. 34 (1996) 993-994
21. Weightman N.C., Allerton K.E., and France J. Bone and prosthetic joint infection with Staphylococcus lugdunensis. J. Infect. 40 (2000) 98-99
22. Ebright J.R., Penugonda N., and Brown W. Clinical experience with Staphylococcus lugdunensis bacteremia: a retrospective analysis. Diagn. Microbiol. Infect. Dis. 48 (2004) 17-21
23. Linehan D., et al. Patterns of exoprotein production in isolates of Staphylococcus schleiferi and Staphylococcus lugdunensis. Biochem. Soc. Trans. 20 (1992) 87S
24. Pfaller M.A., et al. Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program. SENTRY Participants Group. Diagn. Microbiol. Infect. Dis. 33 (1999) 283-297
25. Castro J.G., and Dowdy L. Septic shock caused by Staphylococcus lugdunensis. Clin. Infect. Dis. 28 (1999) 681-682
26. Fleurette J., et al. Clinical isolates of Staphylococcus lugdunensis and S. schleiferi: bacteriological characteristics and susceptibility to antimicrobial agents. Res. Microbiol. 140 (1989) 107-118
27. Pareja J., Gupta K., and Koziel H. The toxic shock syndrome and Staphylococcus lugdunensis bacteremia. Ann. Intern. Med. 128 (1998) 603-604
28. Vandenesch F., et al. Delta-like haemolysin produced by Staphylococcus lugdunensis. FEMS Microbiol. Lett. 62 (1991) 65-68
29. Vandenesch F., et al. agr-related sequences in Staphylococcus lugdunensis. FEMS Microbiol. Lett. 111 (1993) 115-122
30. Novick R.P. Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol. Microbiol. 48 (2003) 1429-1449
31. Donvito B., et al. Synergistic hemolytic activity of Staphylococcus lugdunensis is mediated by three peptides encoded by a non-agr genetic locus. Infect. Immun. 65 (1997) 95-100
32. Donvito B., et al. Distribution of the synergistic haemolysin genes hld and slush with respect to agr in human staphylococci. FEMS Microbiol. Lett. 151 (1997) 139-144
33. von Eiff C., Peters G., and Heilmann C. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect. Dis. 2 (2002) 677-685
34. Lambe Jr. D.W., et al. Pathogenicity of Staphylococcus lugdunensis, Staphylococcus schleiferi, and three other coagulase-negative staphylococci in a mouse model and possible virulence factors. Can. J. Microbiol. 36 (1990) 455-463
35. Ferguson K.P., et al. Comparison of the pathogenicity of three species of coagulase-negative Staphylococcus in a mouse model with and without a foreign body. Can. J. Microbiol. 37 (1991) 722-724
36. Paulsson M., Petersson A.C., and Ljungh A. Serum and tissue protein binding and cell surface properties of Staphylococcus lugdunensis. J. Med. Microbiol. 38 (1993) 96-102
37. Nilsson M., et al. A von Willebrand factor-binding protein from Staphylococcus lugdunensis. FEMS Microbiol. Lett. 234 (2004) 155-161
38. Mitchell J., Tristan A., and Foster T.J. Characterization of the fibrinogen-binding surface protein Fbl of Staphylococcus lugdunensis. Microbiology 150 (2004) 3831-3841
39. Nilsson M., et al. A fibrinogen-binding protein of Staphylococcus lugdunensis. FEMS Microbiol. Lett. 241 (2004) 87-93
40. Frank K.L., and Patel R. Poly-N-acetylglucosamine is not a major component of the extracellular matrix in biofilms formed by icaADBC-positive Staphylococcus lugdunensis isolates. Infect. Immun. 75 (2007) 4728-4742
41. Hébert G.A. Hemolysins and other characteristics that help differentiate and biotype Staphylococcus lugdunensis and Staphylococcus schleiferi. J. Clin. Microbiol. 28 (1990) 2425-2431
42. O'Gara J.P. ica and beyond: biofilm mechanisms and regulation in Staphylococcus epidermidis and Staphylococcus aureus. FEMS Microbiol. Lett. 270 (2007) 179-188
43. Gotz F. Staphylococcus and biofilms. Mol. Microbiol. 43 (2002) 1367-1378
44. Vuong C., et al. A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence. J. Biol. Chem. 279 (2004) 54881-54886
45. Conlon K.M., Humphreys H., and O'Gara J.P. icaR encodes a transcriptional repressor involved in environmental regulation of ica operon expression and biofilm formation in Staphylococcus epidermidis. J. Bacteriol. 184 (2002) 4400-4408
46. Chokr A., et al. Correlation between biofilm formation and production of polysaccharide intercellular adhesin in clinical isolates of coagulase-negative staphylococci. Int. J. Med. Microbiol. 296 (2006) 381-388
47. Kogan G., et al. Biofilms of clinical strains of Staphylococcus that do not contain polysaccharide intercellular adhesin. FEMS Microbiol. Lett. 255 (2006) 11-16
48. Sadovskaya I., et al. Carbohydrate-containing components of biofilms produced in vitro by some staphylococcal strains related to orthopaedic prosthesis infections. FEMS Immunol. Med. Microbiol. 47 (2006) 75-82
49. Kaplan J.B., et al. Enzymatic detachment of Staphylococcus epidermidis biofilms. Antimicrob. Agents Chemother. 48 (2004) 2633-2636
50. Frank K.L., and Patel R. Intravenously administered pharmaceuticals impact biofilm formation and detachment of Staphylococcus lugdunensis and other staphylococci. Diagn. Microbiol. Infect. Dis. 60 (2007) 9-16
51. Bannerman T.L., and Peacock S.J. Staphylococcus, Micrococcus, and other catalase-positive cocci. In: Murray P.R., et al. (Ed). Manual of clinical microbiology. 9th ed. vol. 1 (2007), ASM Press, Washington, DC 390-411
52. Etienne J., et al. Plasmid profiles and genomic DNA restriction endonuclease patterns of 30 independent Staphylococcus lugdunensis strains. FEMS Microbiol. Lett. 55 (1990) 93-97
53. Poitevin-Later F., et al. Cadmium-resistance plasmid in Staphylococcus lugdunensis. FEMS Microbiol. Lett. 78 (1992) 59-63
54. Hellbacher C., Tornqvist E., and Soderquist B. Staphylococcus lugdunensis: clinical spectrum, antibiotic susceptibility, and phenotypic and genotypic patterns of 39 isolates. Clin. Microbiol. Infect. 12 (2006) 43-49
55. Lina B., et al. Comparison of coagulase-negative staphylococci by pulsed-field electrophoresis. FEMS Microbiol. Lett. 71 (1992) 133-138
56. Leung M.J., et al. Colony variation in Staphylococcus lugdunensis. J. Clin. Microbiol. 36 (1998) 3096-3098
57. Seifert H., et al. Staphylococcus lugdunensis pacemaker-related infection. Emerg. Infect. Dis. 11 (2005) 1283-1286
58. Frank K.L., et al. In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates. Antimicrob. Agents Chemother. 51 (2007) 888-895
59. Carroll K.C., and Weinstein M.P. Manual and automated systems for detection and identification of microorganisms. In: Murray P.R., et al. (Ed). Manual of clinical microbiology. 9th ed vol. 1 (2007), ASM Press, Washington, DC 192-244
60. Tee W.S., et al. Staphylococcus lugdunensis carrying the mecA gene causes catheter-associated bloodstream infection in premature neonate. J. Clin. Microbiol. 41 (2003) 519-520
61. Couto I., et al. Identification of clinical staphylococcal isolates from humans by internal transcribed spacer PCR. J. Clin. Microbiol. 39 (2001) 3099-3103
62. Fujita S., et al. Rapid identification of staphylococcal strains from positive-testing blood culture bottles by internal transcribed spacer PCR followed by microchip gel electrophoresis. J. Clin. Microbiol. 43 (2005) 1149-1157
63. Sivadon V., et al. Use of genotypic identification by sodA sequencing in a prospective study to examine the distribution of coagulase-negative Staphylococcus species among strains recovered during septic orthopedic surgery and evaluate their significance. J. Clin. Microbiol. 43 (2005) 2952-2954
64. Kaabia N., et al. Molecular identification of Staphylococcus lugdunensis in a patient with meningitis. J. Clin. Microbiol. 40 (2002) 1824-1825
65. Goldstein E.J., et al. In vitro activity of ceftobiprole against aerobic and anaerobic strains isolated from diabetic foot infections. Antimicrob. Agents Chemother. 50 (2006) 3959-3962
66. Arciola C.R., et al. Prevalence and antibiotic resistance of 15 minor staphylococcal species colonizing orthopedic implants. Int. J. Artif. Organs 29 (2006) 395-401
67. Jarlov J.O., et al. Coagulase-negative staphylococci in Danish blood cultures: species distribution and antibiotic susceptibility. J. Hosp. Infect. 32 (1996) 217-227
68. Higaki S., et al. Distribution and antimicrobial susceptibility of coagulase-negative staphylococci from skin lesions. J. Int. Med. Res. 27 (1999) 191-195
69. You Y.O., et al. Staphylococcus lugdunensis - a potential pathogen in oral infection. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 88 (1999) 297-302
70. Ferreira R.B., et al. Coagulase-negative staphylococci: comparison of phenotypic and genotypic oxacillin susceptibility tests and evaluation of the agar screening test by using different concentrations of oxacillin. J. Clin. Microbiol. 41 (2003) 3609-3614
71. Hussain Z., et al. Correlation of oxacillin MIC with mecA gene carriage in coagulase-negative staphylococci. J. Clin. Microbiol. 38 (2000) 752-754
72. Louie L., et al. Evaluation of a latex agglutination test (MRSA-Screen) for detection of oxacillin resistance in coagulase-negative staphylococci. J. Clin. Microbiol. 39 (2001) 4149-4151
73. CLSI. Performance standards for antimicrobial susceptibility testing; 15th informational supplement. CLSI document M100-S15 (2005), Clinical and Laboratory Standards Institute, Wayne, PA
74. Bourgeois I., et al. Tolerance to the glycopeptides vancomycin and teicoplanin in coagulase-negative staphylococci. Antimicrob. Agents Chemother. 51 (2007) 740-743
75. Dunne Jr. W.M. Effects of subinhibitory concentrations of vancomycin or cefamandole on biofilm production by coagulase-negative staphylococci. Antimicrob. Agents Chemother. 34 (1990) 390-393
76. Rachid S., et al. Effect of subinhibitory antibiotic concentrations on polysaccharide intercellular adhesin expression in biofilm-forming. Staphylococcus epidermidis. Antimicrob. Agents Chemother. 44 (2000) 3357-3363